Hybrid app-based motivational interviewing to prevent excessive gestational weight gain and improve health-promoting lifestyle: a randomized controlled trial

Excessive gestational weight gain (EGWG) is a major risk factor for adverse maternal and neonatal outcomes. Identifying effective interventions to prevent excessive weight gain while promoting healthy lifestyle behaviors and psychological well-being during pregnancy is essential. This study evaluated the effects of hybrid app-based motivational interviewing on preventing EGWG, improving health-promoting lifestyle behaviors, and enhancing psychological health among pregnant women. This randomized controlled trial was conducted from August 2024 to May 2025 among 188 pregnant women at less than 14 weeks of gestation attending prenatal clinics in Babol, Iran. Participants were randomly assigned to the intervention or control group using block randomization ( n = 94 per group). Follow-up was completed by 88 participants in the intervention group and 83 in the control group. The primary analysis followed the intention-to-treat (ITT) principle, with missing data handled using multiple imputation. The intervention consisted of six individual motivational interviewing-based counseling sessions over six consecutive weeks (weeks 15–20 of gestation). Sessions 1, 3, and 5 were conducted in person, whereas sessions 2, 4, and 6 were delivered remotely via a mobile application. Psychoeducational materials were provided through the application following each remote session. The control group received routine prenatal care. Maternal weight was measured at baseline, 28 weeks of gestation, and before delivery. Excessive gestational weight gain (EGWG) was defined according to the 2009 Institute of Medicine guidelines. The Health-Promoting Lifestyle Profile II (HPLP-II) and the 28-item General Health Questionnaire (GHQ-28) were administered at baseline, 28 weeks of gestation, and six weeks postpartum. Independent-samples t-tests were used for unadjusted between-group comparisons, repeated-measures ANOVA for within-group comparisons over time, and ANCOVA for adjusted between-group comparisons. By delivery, excessive weight gain was lower in the intervention group (23.4%) than in the control group (40.4%) ( P = 0.039). Mean weight gain was 2.06 kg lower at week 28 (95% CI: −2.75 to − 1.37, P < 0.001) and 1.56 kg lower at delivery (95% CI: −2.30 to − 0.82, P < 0.001) in the intervention group. For HPLP-II, a marginally statistically significant between-group difference was observed at baseline ( P = 0.049), with higher scores in the intervention group. The intervention group had significantly higher scores at week 28 (127.38 ± 19.43 vs. 107.00 ± 11.52, P < 0.001) and six weeks postpartum (128.78 ± 16.98 vs. 100.31 ± 10.16, P < 0.001). For GHQ, there was no baseline difference ( P = 0.308), but the intervention group had lower scores at week 28 (16.44 ± 3.11 vs. 21.55 ± 4.10, P < 0.001) and six weeks postpartum (17.99 ± 3.47 vs. 22.88 ± 3.59, P < 0.001), indicating better general health. The hybrid app-based motivational interviewing intervention was associated with a lower incidence of excessive gestational weight gain (23.4% vs. 40.4%; absolute risk reduction, 17.0% points) and a lower gestational weight gain at delivery (between-group difference, − 1.56 kg; 95% CI: −2.30 to − 0.82), as well as improved HPLP-II and GHQ-28 scores compared with routine prenatal care. The intervention may be considered for routine prenatal care, pending further evaluation of its cost-effectiveness and implementation feasibility. Trial registration The trial was prospectively registered in the Iranian Registry of Clinical Trials (IRCT20200122046228N6) on 21 April 2024, before participant enrollment began.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-16
DOI
https://doi.org/10.1038/s41598-026-79692-8
Primary Topic
Mobile Health and mHealth Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hybrid app-based motivational interviewing to prevent excessive gestational weight gain and improve health-promoting lifestyle: a randomized controlled trial

Azita Ghanbarpour, Hajar Adib‐Rad, Samira Mohammadi, Mahbobeh Faramarzi et al.
2 links
Scientific Reports
Mobile Health and mHealth Applications
article

Hybrid app-based motivational interviewing to prevent excessive gestational weight gain and improve health-promoting lifestyle: a randomized controlled trial

Azita Ghanbarpour, Hajar Adib‐Rad, Samira Mohammadi, Mahbobeh Faramarzi, Fatemeh Nasiri Amiri, Hossein-Ali Nikbakht, Shabnam Omidvar
article en

Abstract

Excessive gestational weight gain (EGWG) is a major risk factor for adverse maternal and neonatal outcomes. Identifying effective interventions to prevent excessive weight gain while promoting healthy lifestyle behaviors and psychological well-being during pregnancy is essential. This study evaluated the effects of hybrid app-based motivational interviewing on preventing EGWG, improving health-promoting lifestyle behaviors, and enhancing psychological health among pregnant women. This randomized controlled trial was conducted from August 2024 to May 2025 among 188 pregnant women at less than 14 weeks of gestation attending prenatal clinics in Babol, Iran. Participants were randomly assigned to the intervention or control group using block randomization ( n = 94 per group). Follow-up was completed by 88 participants in the intervention group and 83 in the control group. The primary analysis followed the intention-to-treat (ITT) principle, with missing data handled using multiple imputation. The intervention consisted of six individual motivational interviewing-based counseling sessions over six consecutive weeks (weeks 15–20 of gestation). Sessions 1, 3, and 5 were conducted in person, whereas sessions 2, 4, and 6 were delivered remotely via a mobile application. Psychoeducational materials were provided through the application following each remote session. The control group received routine prenatal care. Maternal weight was measured at baseline, 28 weeks of gestation, and before delivery. Excessive gestational weight gain (EGWG) was defined according to the 2009 Institute of Medicine guidelines. The Health-Promoting Lifestyle Profile II (HPLP-II) and the 28-item General Health Questionnaire (GHQ-28) were administered at baseline, 28 weeks of gestation, and six weeks postpartum. Independent-samples t-tests were used for unadjusted between-group comparisons, repeated-measures ANOVA for within-group comparisons over time, and ANCOVA for adjusted between-group comparisons. By delivery, excessive weight gain was lower in the intervention group (23.4%) than in the control group (40.4%) ( P = 0.039). Mean weight gain was 2.06 kg lower at week 28 (95% CI: −2.75 to − 1.37, P < 0.001) and 1.56 kg lower at delivery (95% CI: −2.30 to − 0.82, P < 0.001) in the intervention group. For HPLP-II, a marginally statistically significant between-group difference was observed at baseline ( P = 0.049), with higher scores in the intervention group. The intervention group had significantly higher scores at week 28 (127.38 ± 19.43 vs. 107.00 ± 11.52, P < 0.001) and six weeks postpartum (128.78 ± 16.98 vs. 100.31 ± 10.16, P < 0.001). For GHQ, there was no baseline difference ( P = 0.308), but the intervention group had lower scores at week 28 (16.44 ± 3.11 vs. 21.55 ± 4.10, P < 0.001) and six weeks postpartum (17.99 ± 3.47 vs. 22.88 ± 3.59, P < 0.001), indicating better general health. The hybrid app-based motivational interviewing intervention was associated with a lower incidence of excessive gestational weight gain (23.4% vs. 40.4%; absolute risk reduction, 17.0% points) and a lower gestational weight gain at delivery (between-group difference, − 1.56 kg; 95% CI: −2.30 to − 0.82), as well as improved HPLP-II and GHQ-28 scores compared with routine prenatal care. The intervention may be considered for routine prenatal care, pending further evaluation of its cost-effectiveness and implementation feasibility. Trial registration The trial was prospectively registered in the Iranian Registry of Clinical Trials (IRCT20200122046228N6) on 21 April 2024, before participant enrollment began.

Scientific Reports
Babol University of Medical Sciences (IR)
Good health and well-being
Mobile Health and mHealth Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon